Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.
about
ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluidsGenerating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticityStructural Basis of Cytochrome c Presentation by IE kReduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmissionType-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1.Nuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: relation to specificity of peptide-induced anti-HIV neutralizing antibodiesImmunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes.Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles.Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains.Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.Periodic variation in side-chain polarities of T-cell antigenic peptides correlates with their structure and activityRole of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine.Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero.Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.The development of an AIDS vaccine: progress and promise.Immuno-informatics: Mining genomes for vaccine components.Structural basis of antigen recognition by T lymphocytes. Implications for vaccines.Identification of human immunodeficiency virus (HIV) envelope type-specific T helper cells in an HIV-infected individualMolecular analysis of TCR and peptide/MHC interaction using P18-I10-derived peptides with a single D-amino acid substitution.Low maternal viral loads and reduced granulocyte-macrophage colony-stimulating factor levels characterize exposed, uninfected infants who develop protective human immunodeficiency virus type 1-specific responses.Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro.Structural analysis of a novel rabbit monoclonal antibody R53 targeting an epitope in HIV-1 gp120 C4 region critical for receptor and co-receptor binding.A sequence pattern common to T cell epitopesAnalysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptidesInfluences of antigen processing on the expression of the T cell repertoire. Evidence for MHC-specific hindering structures on the products of processing.Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesisEnhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequenceDetection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected childrenBiological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvantPeptide component vaccine engineering: targeting the AIDS virus.Induction of neutralizing antibodies in rhesus macaques using V3 mimotope peptides.A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes.Priming of anti-human immunodeficiency virus (HIV) CD8+ cytotoxic T cells in vivo by carrier-free HIV synthetic peptides.Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.
P2860
Q24682788-6131C482-F97F-44AF-A40E-964BFDF863CAQ24806405-057AECAC-3C49-4188-AED5-A21A14EA1752Q27638866-EC777D0C-8BF4-4370-B929-9FF8A53E58B8Q28362322-5F70B60F-0CCF-4B11-BC72-B830AE456206Q33560772-739CF58D-B8F2-42F6-BC19-2202B78BD5E4Q33570776-CDCB6944-EACF-4A34-AAC5-77F48A04FFE5Q33639547-F03A6127-D559-441B-A860-AB316E2198DCQ33639792-3459107B-5649-4AC0-88A4-8ACC7AAB0949Q33645169-8C400D02-93C1-433C-875E-683A8FB301DDQ33660809-7BA64110-F0F1-44BE-AC0F-F4DA6A81B3EEQ33794744-2207E957-4833-469F-8713-E81FB86A3A39Q33839448-07044F9D-5DA4-4365-B715-4E0880355E3AQ33973345-46FA0383-71AE-4553-B062-A181087E1E4FQ34126859-777A595B-73BD-4A85-B167-64F08FECFD06Q34197974-66A5D1C8-6898-49DA-A139-97A4A2B4AB7BQ34373003-EB531C0D-4BE0-4CA4-B39A-C5C1EB0ED2D0Q34461381-28A477A4-6A76-4C73-8D6F-FDDAA1E315F9Q34640420-6D4FC4E2-223E-494B-BFE7-62346AAEFE4FQ34675856-290CC7CD-E690-42ED-9A53-F5FF53D67101Q34687622-FC668653-87AF-4F3A-A230-468CF268A636Q35593962-825EC1B0-DFFC-41A4-9C72-55C52DE76033Q35595438-86CB4124-A400-48E6-BFD7-E01F9F788319Q35781187-563656CE-1D01-4E29-A845-96A4A0FDA22AQ35783507-C3E6C0A1-9B63-4B22-8407-FA2BE3083F67Q35837746-14C32A99-4E7A-42F8-A519-A8E078D7C2E4Q35909563-DCC49D3C-9813-4DA0-836F-4817BC31C641Q35973055-CF822CCA-F979-4974-9628-F3EF51B2F455Q36353387-6E3D53D2-3651-461C-B53C-093CEDFFCD95Q36355124-7CA6A74F-DC30-4715-ACB6-4814787DEBC1Q36361373-8406F57F-ACB5-42B9-83D8-E1D1A475ADEEQ36478616-0183C11C-D1FC-4FAE-8B39-EB78389B94A9Q36597984-BEC5DCB3-3084-47A6-B549-40A55A53298BQ36625854-B1BBAEE9-5030-4A81-8E48-6508D01474E2Q36687749-F28136D4-AB4C-4C43-8C45-9BFD74C7E396Q36688133-FE494E26-2A82-4E18-98B6-88F3439DA6CDQ36708999-DF436053-C28A-4AB8-819B-648415525287Q36920319-A1B54B92-C680-4889-ACCF-1B75158087B0Q37542899-B401BA34-2FA5-4606-A15E-B9F4A4525A84Q37610962-82C1F404-7827-419F-9797-6874942E487CQ37634281-CC14240E-D3E1-4F54-8D6D-6678216C4491
P2860
Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Helper T-cell antigenic site i ...... 16-residue synthetic peptide.
@ast
Helper T-cell antigenic site i ...... 16-residue synthetic peptide.
@en
Helper T-cell antigenic site i ...... 16-residue synthetic peptide.
@nl
type
label
Helper T-cell antigenic site i ...... 16-residue synthetic peptide.
@ast
Helper T-cell antigenic site i ...... 16-residue synthetic peptide.
@en
Helper T-cell antigenic site i ...... 16-residue synthetic peptide.
@nl
prefLabel
Helper T-cell antigenic site i ...... 16-residue synthetic peptide.
@ast
Helper T-cell antigenic site i ...... 16-residue synthetic peptide.
@en
Helper T-cell antigenic site i ...... 16-residue synthetic peptide.
@nl
P2093
P2860
P356
P1476
Helper T-cell antigenic site i ...... 16-residue synthetic peptide.
@en
P2093
Cornette JL
Fischinger PJ
Margalit H
Streicher HZ
P2860
P304
P356
10.1073/PNAS.84.12.4249
P407
P50
P577
1987-06-01T00:00:00Z